Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-two ratings firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and fifteen have given a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $202.2222.
Several analysts have recently commented on the stock. Royal Bank Of Canada began coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Morgan Stanley reaffirmed an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Citigroup lowered their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Finally, Northland Securities boosted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th.
Read Our Latest Report on ALAB
Astera Labs Stock Up 0.3%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm’s revenue was up 91.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts anticipate that Astera Labs will post 0.34 earnings per share for the current year.
Insider Activity
In related news, CEO Jitendra Mohan sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. The trade was a 6.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares in the company, valued at approximately $23,781,796.23. This trade represents a 5.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 224,292 shares of company stock worth $27,676,069 in the last quarter. Corporate insiders own 12.50% of the company’s stock.
Institutional Trading of Astera Labs
A number of hedge funds have recently bought and sold shares of ALAB. Spear Advisors LLC purchased a new stake in Astera Labs in the 4th quarter worth approximately $15,787,000. Hsbc Holdings PLC lifted its stake in shares of Astera Labs by 128.5% during the 4th quarter. Hsbc Holdings PLC now owns 83,721 shares of the company’s stock worth $14,126,000 after purchasing an additional 47,081 shares during the period. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new stake in shares of Astera Labs during the fourth quarter worth $75,000. Bank of Hawaii grew its position in shares of Astera Labs by 12.7% in the fourth quarter. Bank of Hawaii now owns 28,580 shares of the company’s stock valued at $4,755,000 after purchasing an additional 3,221 shares during the period. Finally, Reflection Asset Management purchased a new stake in shares of Astera Labs in the fourth quarter valued at $25,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
